A Study of Daratumumab in Patients With Newly Diagnosed Multiple Myeloma
Status:
Active, not recruiting
Trial end date:
2022-09-01
Target enrollment:
Participant gender:
Summary
This is a study to test the safety and effectiveness of the study drug, daratumumab in
combination with carfilzomib, lenalidomide and dexamethasone. The purpose of this study is to
test whether giving daratumumab along with the other drugs (carfilzomib, lenalidomide and
dexamethasone) is safe for patients.